Related Experiment Video
Updated: Jul 11, 2025
11:44
Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
Published on: October 2, 2018
12.6K
Enhancing Stability and Albumin Binding Efficiency of α-Conotoxin GI through Fatty Acid Modification.
Panpan Qi1, Quankuo He1, Junjie Zhang1
1School of Medicine, Guangxi University, Guangxi Key Laboratory of Special Biomedicine, Nanning 530004, China.
Biochemistry
|November 15, 2023
Summary
Fatty acid modification enhances α-conotoxin GI stability and albumin binding. This strategy improves the peptide
Area of Science:
- Medicinal Chemistry
- Peptide Therapeutics
- Neuropharmacology
Background:
- α-Conotoxin GI is a potent blocker of muscle-type acetylcholine receptors.
- It shows promise as a molecular probe and drug discovery lead.
- Improving its stability and binding is crucial for therapeutic development.
Purpose of the Study:
- To synthesize and evaluate fatty acid-modified α-conotoxin GI analogues.
- To assess the impact of fatty acid chain length on stability and albumin binding.
- To confirm the maintenance of pharmacological activity post-modification.
Main Methods:
- Synthesis of four fatty acid-modified α-conotoxin GI analogues.
- In vitro stability assays.
- Albumin binding assays.
- Pharmacological activity assays targeting acetylcholine receptors.
Main Results:
- Fatty acid modification significantly enhanced in vitro stability.
- Albumin binding ability was increased, proportional to fatty acid length.
- Modified analogues retained potent acetylcholine receptor antagonistic activity.
Conclusions:
- Fatty acid modification is an effective strategy to improve conotoxin stability and albumin binding.
- This approach maintains the parent conotoxin's ion channel targeting activity.
- Modified α-conotoxin GI analogues are promising for drug development.
Related Concept Videos
01:32Lipids as Anchors
5.6K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
5.6K
01:29GPI Anchoring of Proteins in the ER Membrane
4.1K
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
4.1K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
167
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
167
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
116
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
116
01:49Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K